We serve Chemical Name:5-Bromo-6-hydroxypicolinic acid CAS:1214385-51-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-Bromo-6-hydroxypicolinic acid
CAS.NO:1214385-51-9
Synonyms:5-Bromo-6-hydroxy-2-pyridinecarboxylic acid;5-Bromo-6-hydroxypyridine-2-carboxylic acid;2-pyridinecarboxylic acid, 5-bromo-6-hydroxy-;5-bromo-6-oxo-1H-pyridine-2-carboxylic acid
Molecular Formula:C6H4BrNO3
Molecular Weight:218.005
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:437.6±45.0 °C at 760 mmHg
Density:2.0±0.1 g/cm3
Index of Refraction:1.666
PSA:70.42000
Exact Mass:216.937454
LogP:0.31
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-Bromo-6-hydroxy-2-pyridinecarboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-bromo-6-oxo-1H-pyridine-2-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-pyridinecarboxylic acid, 5-bromo-6-hydroxy- Use and application,5-Bromo-6-hydroxy-2-pyridinecarboxylic acid technical grade,usp/ep/jp grade.
Related News: In its message to the public, the FDA said that a person should consider being retested if they used Innova’s diagnostic within the past two weeks. 5-Bromo-6-hydroxypicolinic acid manufacturer They have also voiced frustrations about patients from mainland China hiding their travel and medical history, potentially endangering other patients. 5-Bromo-6-hydroxypicolinic acid supplier They have also voiced frustrations about patients from mainland China hiding their travel and medical history, potentially endangering other patients. 5-Bromo-6-hydroxypicolinic acid vendor Green Valley said it would launch the drug ��very soon�� in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug. 5-Bromo-6-hydroxypicolinic acid factory They have also voiced frustrations about patients from mainland China hiding their travel and medical history, potentially endangering other patients.
